Evidence map›Paper›PMID 42095811›Full record

Observational studyRevista medica del Instituto Mexicano del Seguro Social2026

[First cohort: Robotic radical prostatectomy at the Mexican Institute for Social Security].

Seiichi Fuziwara-Ruíz, Narciso Hernández-Toriz, Juan Carlos Huerta-Gómez, Joel Quintero-Becerra, Andrés Martínez-Cornelio, Juan Carlos Zapot-Martínez, Arturo Delgado-Herrera, Cristobal Castro-Chávez, Oscar Pérez-Ramírez

Abstract readEnglish AbstractObservational Study
In one paragraph

Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Seiichi Fuziwara-RuízInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Oncología, Servicio de Urología. Ciudad de México, México.ORCID 0000-0003-4006-5100
Narciso Hernández-TorizInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Oncología, Servicio de Urología. Ciudad de México, México.ORCID 0000-0002-4062-4817
Juan Carlos Huerta-GómezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Oncología, Servicio de Urología. Ciudad de México, México.ORCID 0009-0000-9656-3059
Joel Quintero-BecerraInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Oncología, Servicio de Urología. Ciudad de México, México.ORCID 0000-0001-5058-6116
Andrés Martínez-CornelioInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Oncología, Servicio de Urología. Ciudad de México, México.ORCID 0009-0007-2602-4325
Juan Carlos Zapot-MartínezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Oncología, Servicio de Urología. Ciudad de México, México.ORCID 0000-0002-1859-0665
Arturo Delgado-HerreraInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Oncología, Servicio de Urología. Ciudad de México, México.ORCID 0000-0002-3045-3700
Cristobal Castro-ChávezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Oncología, Servicio de Urología. Ciudad de México, México.ORCID 0009-0000-4234-5021
Oscar Pérez-RamírezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Oncología, Servicio de Urología. Ciudad de México, México.ORCID 0009-0001-0868-3171

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Prostate cancer is the most common cancer in men and the leading cause of malignancy-related mortality in Mexico. The Mexican Institute for Social Security (IMSS for its initialism in Spanish) introduced its first robotic system at the Oncology Hospital of the 21st Century National Medical Center in Mexico City. Objective: To evaluate the accumulated experience, perioperative, oncologic and functional outcomes of the first 200 robot-assisted radical prostatectomy (RARP) cases. Material and methods: A retrospective analysis of 200 patients undergoing RARP for localized prostate cancer was conducted. Perioperative and postoperative variables, pathology results, complications, and one-year continence rates were considered. Results: Mean surgical time was 242.1 minutes (90-600), with a console time of 197.6 minutes (68-495). Mean blood loss was 327.7 cc (10-1800). Positive surgical margins were observed in 34.5% of cases. Complications occurred in 22 patients (11%). No conversions to open surgery or mortality were reported. Mean hospital stay was 2.54 days (2-14). Postoperative antigen was undetectable in 88.5% of patients. The continence rate was 95.7%. Conclusions: The first 200 RARP cases at our institution demonstrate the accumulated experience with the procedure, showing low complication rates. These results are consistent with those of high-volume centers, which require additional long-term functional follow-up.

Indexed as

ProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresAcademies and InstitutesAgedHumansMaleMexicoMiddle AgedOperative TimePostoperative ComplicationsRetrospective StudiesSocial SecurityTreatment OutcomeNeoplasias de la PróstataProcedimientos Quirúrgicos RobotizadosProstatectomíaProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresSeguridad SocialSocial Security

Identifiers

PMID42095811
PMCPMC13186540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.